kinetic analysis was carried out after single intravenous ( 25 mg ) and oral ( 200 mg ) doses of the novel partial opioid agonist meptazinol ( meptid ) in patients with non-cirrhotic liver disease ( ncld ) and biopsy proven cirrhosis .
C0023895
liver disease
C0023890
cirrhosis